Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2022; 68(6): 60-67


Effect of L-tryptophan on the bone biophysical properties and oxygen consumption in rats with diet-induced obesity

O.G. Chaka, V.І. Nosar, А.S. Zinchenko, R.V. Yanko, М.І. Levashov

    Bogomoletz Institute of Physiology NAS of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz68.06.060


Abstract

The purpose of the study was to evaluate the effect of L-tryptophan on the biophysical properties of bone tissue and oxygen consumption in rats with diet-induced obesity. The study was conducted on 40 male 3-months- aged Wistar rats. The photometric determination of phosphorus and calcium concentration in the femoral bones was conducted. The rate of oxygen consumption was measured according to chronoamperograms. The biophysical properties of femurs were measured by a methodic three-point bending test. It was shown that the content of calcium (by 15%) and phosphorus (by 20%) was significantly higher in the femurs of rats that received L-tryptophan (at a dose of 80 mg/kg per os) for 28 days compared to the control parameters. The rate of oxygen consumption, density and biophysical properties of the femurs did not change. As a result of the consumption for three months of a high-calorie diet (580 kcal/100 g) in experimental rats clear features of obesity evolved. Thus, they had a greater visceral fat mass (by 145%), a visceral fat mass to body weight ratio (by 122%), and an obesity index (by 145%). In rats with alimentary obesity, the calcium and phosphorus content in the femurs was significantly reduced by 28 and 24%, respectively, and the rate of oxygen consumption was 45% lower than in control animals. Femur bearing capacity, strength limit, and stiffness were significantly lower, namely on 23, 11, and 37%, respectively. Administration of L-tryptophan to rats, against the background of consumption of a high-calorie diet, inhibited the development of obesity. Visceral fat mass and its ratio to body weight in this group of rats were 38 and 23% lower, respectively, compared to the obese group. The concentration of calcium (by 32%) and phosphorus (by 25%) and oxygen consumption rates (by 31%) were significantly greater compared to rats fed only the high-calorie diet. Our research shows that the administration of L-tryptophan to obese animals can prevent the development of negative changes in bone tissue.

Keywords: obesity; visceral fat; femurs; oxygen consumption; biophysical properties; calcium; phosphorus.

References

  1. Prozorovskiy V. Obesity is the disease of our time. Sci Life. 2020;9:3-8.
  2. Gorbachova VV, Todyrov IM, Plegutsa OI, Khorevina KM. Kalashnikov OO. Influence of bariatric intervention on the course of cardiovascular pathology. Fiziol Zh. 2021;67(5):64-72. [Ukrainian]. CrossRef
  3. Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S, et al. Plasma leptin concentra- tions are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol (Oxf). 2001;55(3):341-7. CrossRef PubMed
  4. Blain H, Vuillemin A, Guillemin F, Durant R, Hanesse B, Talance ND, et al. Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab. 2002;87(3):1030-5. CrossRef PubMed
  5. Elefteriou F, Karsenty G. Bone mass regulation by leptin: a hypothalamic control of bone formation. Pathol Biol. 2004;52(3):148-53. CrossRef PubMed
  6. Morberg CM, Tetens I, Black E, Toubro S, Soerensen TIA, Pedersen O, Astrup A. Leptin and bone mineral density: a cross-sectional study in obese and nonobese men. J Clin Endocrinol Metab. 2003;88(12):5795-800. CrossRef PubMed
  7. Hipmair G, Bohler N, Maschek W, Soriguer F, Rojo- Martinez G, Schimetta W, Pichler R. Serum leptin is correlated to high turnover in osteoporosis. Neuro Endocrinol Lett. 2010;31(1):155-60.
  8. Thomas T, Burguera B, Melton3rd LJ, Atkinson EJ, O'Fallon WM, Riggs BL, Khosla S. Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone. 2001;29(2):114-20. CrossRef PubMed
  9. Ptichkina PA, Skripnikova IA, Novikov VE. Composite composition, bone mass and adipokines in postmeno- pausal women with different cardiovascular risk (SCORE). Osteoporos Osteopat. 2012;15(1):3-6. CrossRef
  10. Heath MJ, Hen R. Serotonin receptors. Genetic insights into serotonin function. Curr Biol. 1995;5(9):997-9. CrossRef PubMed
  11. Lam D, Garfield A, Marston O, Shaw J, Heisler LK Brain. serotonin system in the coordination of food intake and body weight. Pharmacol Biochem Behav. 2010;97(1):84-91. CrossRef PubMed
  12. Namkung J, Kim H, Park S. Peripheral Serotonin: a new player in systemic energy homeostasis. Mol Cells. 2015;38(12):1023-8. CrossRef PubMed PubMedCentral
  13. Giannaccini G, Betth L, Palego L, Marsili A, Santini F, Pelosini C, et al. The expression of platelet serotonin transporter (SERT) in human obesity. BMC Neurosci. 2013;14:128. CrossRef PubMed PubMedCentral
  14. Michalowska M, Znorko B, Kaminski T, Oksztulska- Kolanek E, Pawlak D. New insights into tryptophan and its metabolites in the regulation of bone metabolism. J Physiol Pharmacol. 2015;66(6):779-91.
  15. Bojanowska E, Ciosek J. Can we selectively reduce appetite for energy-dense foods? An overview of phar- macological strategies for modification food preference behavior. Curr Neuropharmacol. 2016;14(2):118-42. CrossRef PubMed PubMedCentral
  16. Cleminson J, Stuart A, Pasco J, Hodge J, Berk M, Sama- rasinghe R, Williams L. Dietary tryptophan and bone health: a cross-sectional, population-based study. Arch Osteoporos. 2020;15(1):7-11. CrossRef PubMed
  17. Al Saedi A, Sharma S, Summers MA, Nurgali K, Duque G. The multiple faces of tryptophan in bone biology. Exp Gerontol. 2020;129.110778. CrossRef PubMed
  18. Jian Fu, Yu-Ren Zhou, Bei-Hua Bao, Meng-Xuan Jia, Yang Zhao, Lei Zhang, et al. Tryptophan Hydroxylase 1 (Tph-1)-targeted bone anabolic agents for osteoporosis. J Med Chem. 2014;57(11):4692-709. CrossRef PubMed
  19. Knets IV, Pfaford GO, Saugozis Y. Deformation and de- struction of solid biological tissues. Riga: Knowledge; 1980.
  20. Schirrmacher K, Lauderbach S, Bingmann D. Oxygen consumption of calvarial bone cells in vitro. J Orthop Res. 1997;15(4):558-62. CrossRef PubMed
  21. Shipelin VA, Trusov NV, Apryatin SA. Shumakova AA, Balakina AS, Riger NA, Gmoshinski IV, Nikityuk DB. Effects of tyrosine and tryptophan in rats with diet- induced obesity. Int J Mol Sci. 2021;22(5):24-9. CrossRef PubMed PubMedCentral
  22. He JL, Zhou XM. Tryptophan hydroxylase 1 (Tph-1)- targeted bone anabolic agents for osteoporosis. J Med Chem. 2014;57(11):4692-709. CrossRef PubMed
  23. Burghardt PR, Tiffany ML, Stohler CS, Hodgkinson C, Shen PH, Enoch MA, Goldman D, Zubieta JK. Leptin regulates dopamine responses to sustained stress in humans. J Neurosci. 2012;32(44):15369-76. CrossRef PubMed PubMedCentral
  24. Anaya JM, Bollag WB, Hamrick MW, Isales CM. The role of tryptophan metabolites in musculoskeletal stem cell aging. Int J Mol Sci. 2020;21(18):66-70. CrossRef PubMed PubMedCentral
  25. Duc P, Karsenty G. The two faces of serotonin in bone biology. J Cell Biol. 2010;191(1):7-13. CrossRef PubMed PubMedCentral

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.